These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1202 related items for PubMed ID: 16870510
1. A survey of newborn screening for cystic fibrosis in Europe. Southern KW, Munck A, Pollitt R, Travert G, Zanolla L, Dankert-Roelse J, Castellani C, ECFS CF Neonatal Screening Working Group. J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510 [Abstract] [Full Text] [Related]
6. Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis. Sarles J, Berthézène P, Le Louarn C, Somma C, Perini JM, Catheline M, Mirallié S, Luzet K, Roussey M, Farriaux JP, Berthelot J, Dagorn JC. J Pediatr; 2005 Sep; 147(3):302-5. PubMed ID: 16182665 [Abstract] [Full Text] [Related]
7. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening. Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A. BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149 [Abstract] [Full Text] [Related]
8. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Pediatrics; 2004 Jun 03; 113(6):1573-81. PubMed ID: 15173476 [Abstract] [Full Text] [Related]
9. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience. Sands D, Zybert K, Mierzejewska E, Ołtarzewski M. Dev Period Med; 2015 Jun 03; 19(1):16-24. PubMed ID: 26003066 [Abstract] [Full Text] [Related]
10. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study. Nshimyumukiza L, Bois A, Daigneault P, Lands L, Laberge AM, Fournier D, Duplantie J, Giguère Y, Gekas J, Gagné C, Rousseau F, Reinharz D. J Cyst Fibros; 2014 May 03; 13(3):267-74. PubMed ID: 24238947 [Abstract] [Full Text] [Related]
11. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels. Massie RJ, Wilcken B, Van Asperen P, Dorney S, Gruca M, Wiley V, Gaskin K. J Pediatr; 2000 Aug 03; 137(2):214-20. PubMed ID: 10931414 [Abstract] [Full Text] [Related]
12. A European consensus for the evaluation and management of infants with an equivocal diagnosis following newborn screening for cystic fibrosis. Mayell SJ, Munck A, Craig JV, Sermet I, Brownlee KG, Schwarz MJ, Castellani C, Southern KW, European Cystic Fibrosis Society Neonatal Screening Working Group. J Cyst Fibros; 2009 Jan 03; 8(1):71-8. PubMed ID: 18957277 [Abstract] [Full Text] [Related]
17. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population. Corbetta C, Seia M, Bassotti A, Ambrosioni A, Giunta A, Padoan R. J Med Screen; 2002 Nov 03; 9(2):60-3. PubMed ID: 12133923 [Abstract] [Full Text] [Related]